{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:48:46Z","timestamp":1792432126441,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.amjmed.2017.12.024","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T21:13:34Z","timestamp":1516137214000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance"],"prefix":"10.1016","volume":"131","author":[{"given":"Osama","family":"Siddique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Ovalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha S.","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.12.024_bib0010","doi-asserted-by":"crossref","first-page":"e12408","DOI":"10.1111\/hel.12408","article-title":"Helicobacter pylori infection and nonmalignant diseases","volume":"22","author":"Sjomina","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG Clinical Guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11739-011-0578-7","article-title":"Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care","volume":"7","author":"Zullo","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-230X-9-23","article-title":"Helicobacter pylori infection: approach of primary care physicians in a developing country","volume":"9","author":"Ahmed","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2036.2009.03935.x","article-title":"Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers","volume":"29","author":"Spiegel","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/hel.12199","article-title":"The prevalence of Helicobacter pylori remains high in African American and Hispanic veterans","volume":"20","author":"Nguyen","year":"2015","journal-title":"Helicobacter"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0055","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/315384","article-title":"Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States","volume":"181","author":"Everhart","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0060","first-page":"897","article-title":"Neighborhood socio-economic characteristics, African ancestry, and Helicobacter pylori sero-prevalence","volume":"23","author":"Epplein","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/1055-9965.EPI-10-1258","article-title":"Race, African ancestry, and Helicobacter pylori infection in a low-income United States population","volume":"20","author":"Epplein","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/gut.35.6.742","article-title":"Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection","volume":"35","author":"Malaty","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/2050640615612934","article-title":"Gastric malt lymphoma: analysis of a series of consecutive patients over 20 years","volume":"4","author":"Moleiro","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0085","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CEG.S109123","article-title":"Autoimmune atrophic gastritis: current perspectives","volume":"10","author":"Minalyan","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0100","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0105","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.3748\/wjg.v20.i36.12781","article-title":"Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment","volume":"20","author":"Testerman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MCG.0000000000000108","article-title":"pylori eradication therapy benefit patients with hepatic encephalopathy? Systematic review","volume":"48","author":"Schulz","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/apt.13560","article-title":"Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis","volume":"43","author":"von Arnim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1053\/j.gastro.2010.08.018","article-title":"A national study of Helicobactor pylori infection in gastric biopsy specimens","volume":"139","author":"Sonnenberg","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-08-0109","article-title":"Helicobacter pylori and esophageal cancer risk: a meta-analysis","volume":"1","author":"Islami","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2004.02203.x","article-title":"Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection\u2014a critical review","volume":"20","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1523-5378.2011.00915.x","article-title":"Accuracy of diagnostic tests for Helicobacter pylori in patients with peptic ulcer bleeding","volume":"17","author":"Choi","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4291\/wjgp.v5.i4.392","article-title":"Treatment of Helicobacter pylori infection: past, present and future","volume":"5","author":"Papastergiou","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MCG.0b013e318277577b","article-title":"Treatment for H. pylori infection: new challenges with antimicrobial resistance","volume":"47","author":"Vakil","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaip.2016.12.010","article-title":"Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy","volume":"5","author":"Lang","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000350719","article-title":"Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection","volume":"88","author":"Venerito","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0165","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0170","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0175","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1006.030744","article-title":"Antimicrobial resistance incidence and risk factors among Helicobacter pylori\u2013infected persons, United States","volume":"10","author":"Duck","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0180","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic resistance of Helicobacter pylori among male United States veterans","volume":"13","author":"Shiota","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0185","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-016-4091-8","article-title":"Helicobacter pylori clarithromycin resistance and treatment failure are common in the USA","volume":"61","author":"Park","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MCG.0b013e31826015b0","article-title":"Nonbismuth quadruple \u201cconcomitant\u201d therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial","volume":"47","author":"Georgopoulos","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MCG.0b013e3182548ad4","article-title":"Comparative study of Helicobacter pylori eradication rates with 5-day quadruple \u201cconcomitant\u201d therapy and 7-day standard triple therapy","volume":"47","author":"Kim","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656566.2013.782286","article-title":"A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)","volume":"14","author":"Marin","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2036.2003.01676.x","article-title":"Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial","volume":"18","author":"Nista","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0215","doi-asserted-by":"crossref","first-page":"163960","DOI":"10.1155\/2015\/163960","article-title":"Comparison of second-line quadruple therapies with or without bismuth for Helicobacter pylori infection","volume":"2015","author":"Jheng","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1523-5378.2009.00664.x","article-title":"Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure","volume":"14","author":"Ueki","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0225","doi-asserted-by":"crossref","first-page":"e0163743","DOI":"10.1371\/journal.pone.0163743","article-title":"Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0230","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.3748\/wjg.v20.i29.9912","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance","volume":"20","author":"Smith","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","article-title":"Review article: rifabutin in the treatment of refractory Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1572-0241.2006.00457.x","article-title":"Third-line rescue therapy with levofloxacin after two H. pylori treatment failures","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0245","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1365-2036.2012.05117.x","article-title":"Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0250","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10620-017-4664-1","article-title":"Efficacy of Vonoprazan-based triple therapy for Helicobacter pylori eradication: a multicenter study and a review of the literature","volume":"62","author":"Tanabe","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2017.12.024_bib0255","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318300135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318300135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:14:18Z","timestamp":1757582058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934318300135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0002934318300135"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.024","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}